Viewing Study NCT00506792


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-02-22 @ 5:08 PM
Study NCT ID: NCT00506792
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2007-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cystic Fibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cystic fibrosis, QAU145, nasal potential difference View